Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland.

× No keyword cloud information.

16 in total

1. Assessing response to therapy in idiopathic pulmonary arterial hypertension: a consensus survey of Canadian pulmonary hypertension physicians.

Authors: Adrienne E Borrie; David N Ostrow; Robert D Levy; John R Swiston
Journal: Can Respir J Date: 2011 Jul-Aug Impact factor: 2.409

Review 2. Pulmonary hypertension-"state of the art" management in 2012.

Authors: Anita Saxena
Journal: Indian Heart J Date: 2012-03-26

Review 3. [Pulmonary arterial hypertension in collagenoses].

Authors: M Claussen; G Riemekasten; M M Hoeper
Journal: Z Rheumatol Date: 2009-10 Impact factor: 1.372

4. Impact of anti-centromere antibodies on pulmonary function test results in patients with systemic sclerosis without established or suspected pulmonary disease.

Authors: J Gunn; J D Pauling; N J McHugh
Journal: Clin Rheumatol Date: 2014-04-22 Impact factor: 2.980

Review 5. Orphan drug development: the increasing role of clinical pharmacology.

Authors: Mariam A Ahmed; Malek Okour; Richard Brundage; Reena V Kartha
Journal: J Pharmacokinet Pharmacodyn Date: 2019-07-23 Impact factor: 2.745

Review 6. Pulmonary hypertension: use of oral drugs in patients with renal insufficiency.

Authors: Sarah Zimner-Rapuch; Sabine Amet; Nicolas Janus; Gilbert Deray; Vincent Launay-Vacher
Journal: Clin Drug Investig Date: 2013-01 Impact factor: 2.859

7. Evaluating factors influencing screening for pulmonary hypertension in systemic sclerosis: does disparity between available guidelines influence clinical practice?

Authors: John D Pauling; Neil J McHugh
Journal: Clin Rheumatol Date: 2011-09-13 Impact factor: 2.980

Review 8. Tadalafil: in pulmonary arterial hypertension.

Authors: Jamie D Croxtall; Katherine A Lyseng-Williamson
Journal: Drugs Date: 2010-03-05 Impact factor: 9.546

Review 9. Ambrisentan.

Authors: Jamie D Croxtall; Susan J Keam
Journal: Drugs Date: 2008 Impact factor: 9.546

Review 10. Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient.

Authors: Christopher J Valerio; John G Coghlan
Journal: Vasc Health Risk Manag Date: 2009-08-06